Malaria Research Related Content

The World Health Organization (WHO) has certified Cabo Verde as a malaria-free country, marking a significant achievement in the global fight against the disease.

Scientists from the University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have taken a huge step forward in combating the global threat of malaria.

A geoengineering strategy to inject aerosols into the stratosphere could have repercussions, with the potential worsening of a tropical malaria outbreak.

By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.

During the height of restrictions and workplace closures for COVID-19, dengue cases dropped across 23 countries in Latin America and Southeast Asia.

Research published in BMJ Global Health has found a hotspot for HIV, tuberculosis and malaria in a regional corner of Africa.

To tackle diseases like malaria, yellow fever and dengue, researchers have been studying the distribution, diversity, and abundance of mosquitos.

The World Health Organisation has recently authorised a malaria vaccine, RTS,S/AS01, which has been successful in pilot schemes launched in 2019.

A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.

Leo Braack, Malaria Consortium’s Senior Vector Control Specialist, recounts the ongoing battle against vector-borne diseases and shares why the need for new mosquito control tools has become critical.

Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.

Researchers from the University of Oxford and their partners have reported that the malaria vaccine, R21/Matrix-M, has demonstrated high-level efficacy of 77%.

Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.

Tableau, Mapbox, Exasol, and Alteryx commit $4.3 million to accelerate malaria elimination efforts for more than 60 million people.

On 18th April, a landmark £2.9bn ($4.1bn) commitment was made to invest in ridding the Commonwealth of malaria

NIAID-funded research could aid antimalarial drug development

Researchers have discovered new processes that allow malaria parasites to escape red blood cells and infect other cells, offering potential new treatment targets

David H Peyton. Ph.D., Professor of Chemistry at Portland State University explores the progress being made on malaria in the world today The annual report issued by the World Health Organization (WHO) that tracks malaria world-wide came out at the end of November 2017 and it was not reassuring to...

Dr James Tibenderana from Malaria Consortium unveils the facts about the global goal to eliminate malaria In the past decade, the aspiration of malaria elimination has been high on the agenda. Reducing malaria deaths and the number of diagnosed malaria cases by at least 90% and eliminating it in at...

Professor of Entomology at Louisiana State University Agricultural Center, Timothy D. Schowalter outlines the fundamentals of IPM